iHuman
9 hedge funds and large institutions have $24.4M invested in iHuman in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0.51% less ownership
Funds ownership: 4.93% → 4.42% (-0.51%)
26% less capital invested
Capital invested by funds: $32.8M → $24.4M (-$8.37M)
31% less funds holding
Funds holding: 13 → 9 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.39M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.31M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$589K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$550K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$5.18M |
| 2 |
TAMH
Taikang Asset Management (HK)
Hong Kong
|
-$1.36M |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
-$630K |
| 4 |
Millennium Management
New York
|
-$371K |
| 5 |
BlackRock
New York
|
-$287K |
IH Hedge Fund Activity: Q2 2021 in Review
9 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q2 2021, worth a combined $24.4M — down 26% from $32.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IH and 2 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was Morgan Stanley, adding an estimated $1.39M. The largest seller was Manulife (Manufacturers Life Insurance), exiting entirely with an estimated $5.18M sold.
- 9 institutional investors held iHuman (IH) as of Q2 2021, down from 13 in Q1 2021.
- Funds reported $24.4M of iHuman stock for Q2 2021, down 26% quarter-over-quarter.
- 2 funds opened new iHuman positions in Q2 2021 and 6 closed out, a net change of -4 holders.
- The largest iHuman buyer in Q2 2021 was Morgan Stanley, an estimated $1.39M added.
- The largest iHuman seller in Q2 2021 was Manulife (Manufacturers Life Insurance), an estimated $5.18M sold.
Based on aggregated 13F filings for Q2 2021.